Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

216.5000 USD 3.3300 1.56%

As of 09:50:53 ET on 05/04/2015.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 214.2200 High - Low: 216.5000 - 214.0000 Primary Exchange: NYSE Arca
Volume: 152,674 52-Week Range: 119.0000 - 244.9800 Beta vs SPSIBITR: 0.9987

ETF Chart for XBI

No chart data available.
  • XBI:US 215.4600
  • 1D
  • 1M
  • 1Y
213.1700
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2015-05-01) 213.3336
Assets (M) (on 2015-05-01) 2,101.3350
Shares out (M) 9.85
Market Cap (M) 2,099.72
% Premium -0.08
Average 52-Week % Premium 0.0044
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-03-20) 0.2454
Dividend Yield (ttm) 0.90%

Performance for XBI

1-Month -3.45% 1-Year +65.36%
3-Month +6.88% 3-Year +38.77%
Year To Date +14.44% 5-Year +29.12%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 05/01/2015
Name Position Value % of Total
Dyax Corp 1,322,001 32,990,535 1.571%
Esperion Therapeutics Inc 307,488 30,871,795 1.470%
Auspex Pharmaceuticals Inc 289,334 29,208,267 1.391%
Momenta Pharmaceuticals Inc 1,536,004 27,924,553 1.330%
Inovio Pharmaceuticals Inc 3,248,560 27,352,875 1.303%
Prothena Corp PLC 797,634 26,840,384 1.278%
Bluebird Bio Inc 190,700 26,495,858 1.262%
Amicus Therapeutics Inc 2,472,391 25,811,762 1.229%
Incyte Corp 256,088 25,168,329 1.199%
Regeneron Pharmaceuticals Inc 53,231 25,080,318 1.194%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil